Heart failure in grown-up congenital heart disease

Alessia Faccini1, Angelo Micheletti1, Diana G Negura1

  • 1Pediatric and Adult Congenital Heart Center, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy.

Minerva Cardioangiologica
|January 13, 2018
PubMed

Insights

Adults with congenital heart disease (ACHD) face increased heart failure (HF) hospitalizations and mortality. Early identification and dedicated monitoring are crucial for managing HF in this growing population.

Area of Science:

  • Cardiology
  • Adult Congenital Heart Disease (ACHD)

Background:

  • Increasing survival rates in congenital heart disease (CHD) have shifted focus to adult populations (ACHD).
  • Adult congenital heart disease patients experience rising hospitalization rates due to heart failure (HF).
  • ACHD patients with HF face a five-fold higher mortality risk compared to compensated patients.

Purpose of the Study:

  • To highlight the unique challenges in diagnosing and managing heart failure (HF) in adult congenital heart disease (ACHD) patients.
  • To emphasize the need for specialized monitoring and management strategies for HF in ACHD.

Main Methods:

  • Review of current diagnostic and therapeutic strategies for HF in ACHD.
  • Analysis of HF prevalence in specific ACHD conditions like tetralogy of Fallot, single ventricles, and post-Mustard operation.

Main Results:

  • Heart failure predominantly affects ACHD patients with specific conditions, including tetralogy of Fallot, single ventricles, and those post-Mustard operation.
  • Standard diagnostic and therapeutic approaches for acquired HF may not be fully adequate or timely for ACHD patients.
  • Unusual signs and symptoms can delay HF identification in ACHD.

Conclusions:

  • Dedicated monitoring units are essential for timely HF identification and management in ACHD.
  • Current therapeutic management for HF in ACHD mirrors acquired HF, despite a lack of specific large randomized trials.
  • Proactive and specialized care is imperative for improving outcomes in ACHD patients with heart failure.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
966
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
402
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.0K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
369